|
|
|
Volumn 26, Issue 1, 1999, Pages 3-8
|
|
Efficacy and safety assessment of tolmetin sodium (400 mg tid) vs naproxen sodium (275 mg tid) for the treatment of acute upper respiratory tract infection symptoms;Valoracion de la eficacia y seguridad de tolmetin sodico (400 mg c/8 h) vs naproxen sodico (275 mg c/8 h) para el tratamiento sintomatico de las infecciones respiratorias superiores
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMOXICILLIN;
ANTIBIOTIC AGENT;
ANTIHISTAMINIC AGENT;
CEPHALOSPORIN DERIVATIVE;
COTRIMOXAZOLE;
ERYTHROMYCIN;
MUCOLYTIC AGENT;
NAPROXEN;
PROCAINE PENICILLIN;
TOLMETIN;
ADOLESCENT;
ADULT;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
MALE;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY TRACT INFLAMMATION;
SINGLE BLIND PROCEDURE;
UPPER RESPIRATORY TRACT INFECTION;
|
|
EID: 0033450994
PISSN: 01852108
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (7)
|
